Healios K.K.
4593.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥19 | ¥22 | ¥38 | ¥18 |
| % Growth | -13.6% | -42.1% | 111.1% | – |
| Cost of Goods Sold | ¥113 | ¥135 | ¥97 | ¥30 |
| Gross Profit | -¥94 | -¥113 | -¥59 | -¥12 |
| % Margin | -494.7% | -513.6% | -155.3% | -66.7% |
| R&D Expenses | ¥467 | ¥584 | ¥482 | ¥486 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥203 | ¥168 | ¥222 | ¥372 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| Operating Expenses | ¥670 | ¥752 | ¥704 | ¥858 |
| Operating Income | -¥764 | -¥865 | -¥763 | -¥870 |
| % Margin | -4,021.1% | -3,931.8% | -2,007.9% | -4,833.3% |
| Other Income/Exp. Net | ¥1,333 | -¥1,260 | -¥1,816 | ¥1,313 |
| Pre-Tax Income | ¥569 | -¥2,125 | -¥2,579 | ¥443 |
| Tax Expense | ¥6 | ¥21 | -¥16 | ¥195 |
| Net Income | ¥563 | -¥2,148 | -¥2,561 | ¥256 |
| % Margin | 2,963.2% | -9,763.6% | -6,739.5% | 1,422.2% |
| EPS | 4.89 | -20.31 | -26.72 | 2.84 |
| % Growth | 124.1% | 24% | -1,040.8% | – |
| EPS Diluted | 4.89 | -20.31 | -26.72 | 2.84 |
| Weighted Avg Shares Out | 115 | 106 | 96 | 90 |
| Weighted Avg Shares Out Dil | 115 | 106 | 96 | 90 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥267 | ¥227 | ¥273 | ¥0 |
| Interest Expense | ¥0 | ¥1,521 | ¥2,108 | -¥1,368 |
| Depreciation & Amortization | ¥68 | ¥67 | ¥68 | ¥80 |
| EBITDA | ¥637 | -¥536 | -¥403 | -¥786 |
| % Margin | 3,352.6% | -2,436.4% | -1,060.5% | -4,366.7% |